<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210607051508N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-06-21</date_registration>
      <primary_sponsor>Ahvaz University of Medical Sciences</primary_sponsor>
      <public_title>The effect of pain neuroscience education on the treatment of chronic neck pain</public_title>
      <acronym>PNE</acronym>
      <scientific_title>The effect of pain neuroscience education with and without conventional physical therapy  on psychosocial factors, function and pain in people with chronic neck pain - a clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-06-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/56783</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization is performed by Random Allocation computer software (version 1.1 of Isfahan University of Medical Sciences, Iran) by a statistician 
Which has no role in the study in such a way that a random order of two letters A (intervention) and B (control) in blocks will be made with random numbers 4 and 6 (For example ABBA and ABABA). A research assistant then puts them in sealed envelopes. Before starting the intervention, one of the researchers opens one of the envelopes and thus the person will be placed in one of the two intervention groups (conventional physiotherapy with pain neuroscience education) or control (conventional physiotherapy), Blinding description: A physiotherapist who has no information about patients' allocation and treatment will perform the assessments. The participants will receive information about their treatment program, but they will not be informed if they are in intervention or control group, and for this purpose we will make arrangements so that patients do not see each other. Patients in the intervention group receive treatment on even days and the control group receives treatment on odd days. A statistician who has no information about patients' allocation will perform the statistical analysis.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Neck pain.</hc_freetext>
      <i_freetext>Intervention 1: Control group: conventional physiotherapy treatment, Individuals 12 sessions of therapy (4 weeks of frequency therapy 3 times a week) including 1-20 minutes of TENS and hot packs 2- Exercises to improve mobility (stretching exercises) 3- Exercises that aim to use deep muscles 4- Endurance exercises (Endurance) 5- They will receive strengthening exercises. Intervention 2: Intervention group: conventional physiotherapy treatment with pain neuroscience education. In this study, people will be received 12 sessions of treatment (4 weeks of treatment with frequency 3 times a week), in the first 4 sessions of treatment, conventional physiotherapy treatment with pain neuroscience education in addition to conventional physiotherapy treatment, will be received pain neuroscience education.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
This clinical trial will be an research article and its protocol, results report and statistical analysis will be published to be used by therapists.

When:
If the journal has requested access to the data at any time, the data will be provided.

To whom:
Journal editors and Reviewers

Conditions:
Sometimes for re-analysis or for use in meta-analysis studies

Where to obtain:
Project manager

How to obtain:
It should be send email to project manager and after reviewing the reason for requesting the data, they will be send

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hosein Kouhzad Mohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Physical therapy Department, Rehabilitation School, opposite the MRI Building, Jundishapour University of Medical Sciences, Ahvaz</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6135733133</zip>
        <telephone>+98 61 3374 3101</telephone>
        <email>kouhzad@yahoo.com</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hosein Kouhzad Mohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Khozestan</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6135733133</zip>
        <telephone>+98 61 3374 3101</telephone>
        <email>kouhzad@yahoo.com</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age between 18-65 years
Nonspecific neck pain with a history of at least 12 weeks (chronic)
Ability to understanding, speaking and writing in Persian
Has not used any other treatment 6 weeks before participating in this project and during it. (To get steady state)
Minimum visual analog scale (VAS) 30 of100 mm
Confirmation of central sensitization in people with CSI questionnaire (score above 40 CSI questionnaire is the reason for central sensitization)</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Cancer, fracture, metabolic diseases, rheumatism, cardiovascular, neurological disorders and osteoporosis
Neck  radiculopathy, myelopathy and dizziness
People with widespread pain disorders such as fibromyalgia syndrome or chronic fatigue syndrome
Psychiatric disorders</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M50.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Cervical disc disorder, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: conventional physiotherapy treatment, Individuals 12 sessions of therapy (4 weeks of frequency therapy 3 times a week) including 1-20 minutes of TENS and hot packs 2- Exercises to improve mobility (stretching exercises) 3- Exercises that aim to use deep muscles 4- Endurance exercises (Endurance) 5- They will receive strengthening exercises.</i_keyword>
      <i_keyword>Intervention group: conventional physiotherapy treatment with pain neuroscience education. In this study, people will be received 12 sessions of treatment (4 weeks of treatment with frequency 3 times a week), in the first 4 sessions of treatment, conventional physiotherapy treatment with pain neuroscience education in addition to conventional physiotherapy treatment, will be received pain neuroscience education.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Score of 100 mm visual analog scale to assess pain intensity. Timepoint: Pre intervention, Post intervention, one month and 3 months after baseline. Method of measurement: Visual Analogue Scale.</prim_outcome>
      <prim_outcome>Central Sensitization Inventory questionnaire to assess central sensitivity. Timepoint: Pre intervention, Post intervention, one month and 3 months after baseline. Method of measurement: Central Sensitization Inventory questionnaire score.</prim_outcome>
      <prim_outcome>Lutron Model 5020 Digital Tensile and pressure Algometer for Measuring Pressure Pain Threshold (PPT). Timepoint: Pre intervention, Post intervention, one month and 3 months after baseline. Method of measurement: Digital Tensile and pressure Algometer.</prim_outcome>
      <prim_outcome>Score of Neurophysiology of Pain Questionnaire to evaluate the concept of biological mechanism of pain. Timepoint: Pre intervention, Post intervention, one month and 3 months after baseline. Method of measurement: Neurophysiology of Pain Questionnaire.</prim_outcome>
      <prim_outcome>Neck Disability Index  questionnaire  for disability evaluation. Timepoint: Pre intervention, Post intervention, one month and 3 months after baseline. Method of measurement: Neck Disability Index  questionnaire score.</prim_outcome>
      <prim_outcome>Pain Catastrophizing Scale to assess pain catastrophizing. Timepoint: Pre intervention, Post intervention, one month and 3 months after baseline. Method of measurement: Pain Catastrophizing Scale score.</prim_outcome>
      <prim_outcome>Tampa Scale for Kinesiophobia Questionnaire to assess fear of movement. Timepoint: Pre intervention, Post intervention, one month and 3 months after baseline. Method of measurement: Tampa Scale for Kinesiophobia Questionnaire score.</prim_outcome>
      <prim_outcome>Pain Awareness and Vigilance questionnaire  to assess pain awareness and alertness. Timepoint: Pre intervention, Post intervention, one month and 3 months after baseline. Method of measurement: Pain Awareness and Vigilance questionnaire score.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Quality of life score. Timepoint: Pre Intervention, Post Intervention,  one month and three months after baseline. Method of measurement: Score of  SF3 6 questionnaires to assess the quality of life.</sec_outcome>
      <sec_outcome>Score of a person's perception of their illness. Timepoint: Pre Intervention, Post Intervention,  one month and three months after baseline. Method of measurement: Score of  Brief illness perception questionnaire to assess a person's perception of their illness.</sec_outcome>
      <sec_outcome>General measurement of the rate of change. Timepoint: Pre Intervention, Post Intervention,  one month and three months after baseline. Method of measurement: General review of the amount of changes with the general form of the amount of changes.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Ahvaz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-05-16</approval_date>
        <contact_name>Ahvaz Jundishapur University of Medical Sciences</contact_name>
        <contact_address>No.5, Yas Ave., Shahrak Aghajari Area., Ahvaz City َAhvaz Khouzestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
